We live in troubled times.

However, even in times of uncertainty, the C-suite searches for strategic opportunities to unlock long-term value.

Below are insights that can drive growth in the medtech space.

1. Opportunity Mindset: Despite geopolitical uncertainty, leading CEOs are still committed to transformation, viewing it as the process of finding the silver lining of opportunity in global chaos.

CEOs prioritize long-term transformation over quick fixes.

Among other benefits, strategic data helps CEOs make opportunity decisions on new markets, products, adjacencies and/or innovations with greater confidence.
Medi-Vantage provides data to answer strategic questions, helping you and your team prioritize opportunities.

2. M&A Activity: 2025 is expected to see significant M&A activity, with 70% of CEOs planning to continue deal activity.

The overall appetite for M&A has increased, driven by technological advancements, market consolidation, the need for cost savings, and expansion into new markets or geographies.

Medi-Vantage helps medtech and VC investors with M&A due diligence to ensure that the claims entrepreneurs are making meet the needs of the acquirer and end user.
We decrease M&A risk by adding in-depth clinical due diligence.

3. Price Increases: Medtech companies are raising prices in response to inflation and economic uncertainty.

In a report that includes data from the medtech sector, price growth in 1Q25 accelerated due to tariffs.

Pricing is a sweet-spot here at Medi-Vantage. We help develop pricing models for medtech companies to address shrinking gross margins due to tariffs, price increases in anticipation of tariffs, and global uncertainty.
We also provide value based pricing for disruptive, new devices or services.

Call us. Let us help you grow the business.

References

EY-Parthenon CEO Outlook Survey 1Q25 report

Chief Executive’s latest CEO Confidence Index

CEO Confidence Plummets in Q1 2025 as More Than Two-Thirds Brace for Negative Impacts of Tariffs

Manufacturing PMI® at 50.3% February 2025 Manufacturing ISM® Report On Business®